{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:50:19Z","timestamp":1786978219751,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Cancer-associated thrombosis (CAT) is a major cause of morbidity and mortality in patients with malignancy. Biomarkers of hypercoagulability and thromboinflammation may improve risk stratification and support personalised thromboprophylaxis, but evidence remains heterogeneous, particularly in cervical cancer. A systematic review was conducted according to PRISMA 2020. PubMed\/MEDLINE, Scopus, Embase, and Web of Science were searched for studies published between January 2009 and March 2025 evaluating biological, molecular, genetic, and imaging biomarkers associated with hypercoagulability and thromboinflammation in women withcervical cancer. Evidence from breast cancer and broader CAT studies was incorporated to provide translational context. Owing to substantial methodological heterogeneity, findings were synthesised qualitatively. Twenty-five cervical cancer studies met eligibility criteria. D-dimer was the most extensively investigated biomarker and was consistently associated with VTE risk, although specificity was limited. Biomarkers of thrombin generation and fibrinolytic activation, including thrombin\u2013antithrombin complexes, prothrombin fragment 1+2, and plasmin\u2013\u03b12-antiplasmin complex, demonstrated greater mechanistic specificity. Multimarker panels integrating coagulation, fibrinolysis, endothelial injury, platelet activation, and inflammation showed superior predictive performance compared with single biomarkers. Emerging biomarkers, including circulating tumour DNA, extracellular vesicles, and microRNAs, further supported tumour-driven thromboinflammation. SERPINE1 and F2 gene variants were associated with thrombotic risk and adverse prognosis. Current evidence supports further evaluation of integrated multimodal biomarker strategies for CAT risk assessment, but prospective, standardised, tumour-specific studies are required before biomarker-guided approaches can be implemented in clinical practice.<\/jats:p>","DOI":"10.3390\/ijms27167302","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:26Z","timestamp":1786968086000},"page":"7302","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer"],"prefix":"10.3390","volume":"27","author":[{"given":"Dana","family":"Taizhanova","sequence":"first","affiliation":[{"name":"Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan"},{"name":"Multidisciplinary Hospital No. 1, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8004-0540","authenticated-orcid":false,"given":"Nurgul","family":"Serikbay","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan"},{"name":"Clinic of Karaganda Medical University, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-8845","authenticated-orcid":false,"given":"Pedro Henrique Fernandes do Carmo Las","family":"Casas","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-6912","authenticated-orcid":false,"given":"Jovana","family":"Mijucic","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"},{"name":"Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodaubay","family":"Roza","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Zubkov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatology, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Toleubekova","sequence":"additional","affiliation":[{"name":"Multidisciplinary Hospital No. 1, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bovt","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, NJSC Karaganda Medical University, 100000 Karaganda, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-467X","authenticated-orcid":false,"given":"Zoubida","family":"Tazi Mezalek","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Mohammed V University, Rabat 10000, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-4782","authenticated-orcid":false,"given":"Patrick","family":"Vandreden","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"},{"name":"Diagnostica Stago, 92230 Gennevilliers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1469-3074","authenticated-orcid":false,"given":"Mohammed A.","family":"Baghdadi","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Saleem","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"},{"name":"Thrombosis and Hemostasis Research Laboratories, Centre of Translational Research and Education,  Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Tafur","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vascular Medicine, Endeavor Health, Evanston, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-7663","authenticated-orcid":false,"given":"Eleftheria Elmina","family":"Lefkou","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"},{"name":"Blood Transfusion and Haemostasis Unit, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41334 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2219-7049","authenticated-orcid":false,"given":"Fakiha","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Research Laboratories, Centre of Translational Research and Education,  Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2901-0339","authenticated-orcid":false,"given":"Prakasha","family":"Kempaiah","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Research Laboratories, Centre of Translational Research and Education,  Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed","family":"Fareed","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Research Laboratories, Centre of Translational Research and Education,  Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bitsadze","sequence":"additional","affiliation":[{"name":"Thrombosis Centre, Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2316-6348","authenticated-orcid":false,"given":"Grigoris T.","family":"Gerotziafas","sequence":"additional","affiliation":[{"name":"CaVITE Research Team, Consultation Thrombosis in Oncology (CoThON), Saint-Antoine Research Centre (CRSA), INSERM UMR_S_938, Saint-Antoine University Hospital, University Institute of Cancerology (UIC), Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne University, 75012 Paris, France"},{"name":"Thrombosis and Hemostasis Research Laboratories, Centre of Translational Research and Education,  Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, IL 60153, USA"},{"name":"Thrombosis Centre, Department of Obstetrics, Gynecology and Perinatal Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"},{"name":"VAS\u2014European Independent Foundation in Angiology\/Vascular Medicine, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of Cancers Associated with Venous Thromboembolism","volume":"343","author":"Olsen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"ref_7","first-page":"475","article-title":"Direct Medical Costs of Venous Thromboembolism and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis From 30 Managed Care Organizations","volume":"13","author":"Spyropoulos","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: Biological and clinical aspects","volume":"11","author":"Falanga","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","article-title":"Mechanisms and biomarkers of cancer-associated thrombosis","volume":"225","author":"Kim","year":"2020","journal-title":"Transl. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtha.2024.09.009","article-title":"Circulating tumor DNA predicts venous thromboembolism in patients with cancers","volume":"23","author":"Ma","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOH.0000000000000521","article-title":"Cancer cell-derived tissue factor-positive extracellular vesicles: Biomarkers of thrombosis and survival","volume":"26","author":"Hisada","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","article-title":"Microparticle-associated tissue factor activity: A link between cancer and thrombosis?","volume":"5","author":"Tesselaar","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"26901","DOI":"10.3402\/jev.v4.26901","article-title":"Extracellular vesicles, tissue factor, cancer and thrombosis\u2014Discussion themes of the ISEV 2014 Educational Day","volume":"4","author":"Gardiner","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Beck, S., Hochreiter, B., and Schmid, J.A. (2022). Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.859863"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy","volume":"15","author":"Zwicker","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7754\/Clin.Lab.2019.190905","article-title":"Cervical Cancer Associated Biomarkers of Identify High Risk of Venous Thrombosis","volume":"66","author":"Liang","year":"2020","journal-title":"Clin. Lab."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Qiu, Y., Han, S., Ji, Y., Lu, Z., and Huang, X. (2024). Development of a thrombin-antithrombin complex detection kit and study in venous thromboembolism complicated by cervical cancer. BMC Biotechnol., 24.","DOI":"10.1186\/s12896-024-00930-w"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/03936155231163599","article-title":"Analysis of systemic inflammatory and coagulation biomarkers in advanced cervical cancer: Prognostic and predictive significance","volume":"38","author":"Li","year":"2023","journal-title":"Int. J. Biol. Markers"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhou, K., Zhang, J., Zheng, Z.-R., Zhou, Y.-Z., Zhou, X., Wang, L.-D., Suo, B., Jiang, X.-F., Liu, P.-J., and Wang, D.-H. (2020). Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis. Clin. Appl. Thromb., 26.","DOI":"10.1177\/1076029620971041"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ma, J., Tang, Y., Zhou, J., Zhao, A., and Shi, J. (2025). Plasmin-Antiplasmin Complex as a New Predictive Marker of Postoperative Venous Thromboembolism in Patients with Gynecologic Malignancy. Clin. Appl. Thromb., 31.","DOI":"10.1177\/10760296251324918"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11239-024-02983-2","article-title":"Haemostatic gene variations in cervical cancer-associated venous thrombosis: Considerations for clinical strategies","volume":"57","author":"Neto","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-36161-w","article-title":"Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer","volume":"13","author":"Neto","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Costa, M.T., Neto, B.V., da Silva, J.B., Carvalho, L., Salgado, L., Pereira, D., Adega, F., Tavares, V., and Medeiros, R. (2025). Venous Thrombogenesis and Cervical Cancer: Plasma MicroRNAs as Prognostic Indicators of Tumor Behavior. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199796"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100123","DOI":"10.1016\/j.rpth.2023.100123","article-title":"Mechanisms of cancer-associated thrombosis","volume":"7","author":"Hisada","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2016.06.012","article-title":"Significance of venous thromboembolism in women with cervical cancer","volume":"142","author":"Matsuo","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mco.2022.2541","article-title":"Incidence and risk factors of perioperative venous thromboembolism in patients with cervical cancer","volume":"16","author":"Zhao","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.31557\/APJCP.2019.20.4.1025","article-title":"Combination of Preoperative D-Dimer and Platelet Distribution width Predicts Postoperative Deep Venous Thrombosis in Patients with Cervical Carcinoma","volume":"20","author":"Li","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000365477","article-title":"Prognostic Significance of Pretreatment Plasma Fibrinogen and Platelet Levels in Patients with Early-Stage Cervical Cancer","volume":"79","author":"Zhao","year":"2015","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/smj.smj_59_17","article-title":"D-dimer levels as marker of deep vein thrombosis in patients with cervical cancer: A study of a northern Nigerian patient population","volume":"22","author":"Zayyan","year":"2019","journal-title":"Sahel Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/jog.14233","article-title":"Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer","volume":"46","author":"Tasaka","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3332\/ecancer.2023.1501","article-title":"Potential clinical utility of plasma D-dimer levels among women with cervical cancer in Lagos, Nigeria","volume":"17","author":"Tietie","year":"2023","journal-title":"ecancermedicalscience"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cheng, S., Gao, H., Li, Y., Shi, X., Li, X., Yang, T., Teng, D., Meng, T., and Shi, J. (2024). Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis in Patients With Cervical Cancer. Clin. Appl. Thromb., 30.","DOI":"10.1177\/10760296241240747"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/IJWH.S481692","article-title":"The Association Between D-Dimer Levels and Recurrence in Patients with Early-Stage Cervical Cancer after Surgical Treatment","volume":"16","author":"Chen","year":"2024","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3929435","DOI":"10.1155\/2020\/3929435","article-title":"The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"647.e1","DOI":"10.1016\/j.ajog.2009.01.008","article-title":"Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer","volume":"200","author":"Polterauer","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-024-03649-2","article-title":"Development and validation of a nomogram for predicting venous thromboembolism risk in post-surgery patients with cervical cancer","volume":"22","author":"Chen","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tsai, S.-J., Ruan, Y.-X., Lee, C.-C., Lee, M.-S., Chiou, W.-Y., Lin, H.-Y., Hsu, F.-C., Su, Y.-C., and Hung, S.-K. (2012). The incidence of venous thromboembolism in cervical cancer: A nationwide population-based study. BMC Res. Notes, 5.","DOI":"10.1186\/1756-0500-5-316"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/s41598-021-87606-z","article-title":"Incidence and risk factors of VTE in patients with cervical cancer using the Korean national health insurance data","volume":"11","author":"Yuk","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Pi\u0161kur, I., Topolovec, Z., Bakula, M., Zagorac, I., Vranje\u0161, I.M., and Vidosavljevi\u0107, D. (2023). Expression of Vascular Endothelial Growth Factor-A (VEGF-A) in Adenocarcinoma and Squamous Cell Cervical Cancer and Its Impact on Disease Progression: Single Institution Experience. Medicina, 59.","DOI":"10.3390\/medicina59071189"},{"key":"ref_43","first-page":"4075","article-title":"Expression of tissue factor in human cervical carcinoma tissue","volume":"16","author":"Zhao","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.17749\/2313-7347\/ob.gyn.rep.2022.364","article-title":"Immunothrombosis in cancer patients: Contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor","volume":"16","author":"Slukhanchuk","year":"2023","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000517320","article-title":"Inflammatory Biomarkers as Promising Predictors of Prognosis in Cervical Cancer Patients","volume":"99","author":"Domenici","year":"2021","journal-title":"Oncology"},{"key":"ref_46","first-page":"138","article-title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma","volume":"9","author":"Nakamura","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","article-title":"High D-dimer levels are associated with poor prognosis in cancer patients","volume":"97","author":"Ay","year":"2012","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0049-3848(12)70008-7","article-title":"Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients","volume":"129","author":"Ay","year":"2012","journal-title":"Thromb. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: A development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/asheducation.V2012.1.626.3798655","article-title":"Cancer-associated thrombosis: Updates and controversies","volume":"2012","author":"Khorana","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3324\/haematol.2019.228981","article-title":"Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer","volume":"105","author":"Giaccherini","year":"2019","journal-title":"Haematologica"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Otero, R., Solier-L\u00f3pez, A., S\u00e1nchez-L\u00f3pez, V., Oto, J., Arellano, E., Mar\u00edn, S., Jara-Palomares, L., El\u00edas, T., Asencio, M.I., and Blasco-Esquivias, I. (2022). Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study). Cancers, 14.","DOI":"10.3390\/cancers14112771"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.acvd.2023.11.006","article-title":"Recurrent venous thromboembolism in anticoagulated cancer patients: Diagnosis and treatment","volume":"117","author":"Bertoletti","year":"2023","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Marchetti, M., Gomez-Rosas, P., Russo, L., Tartari, C.J., Bolognini, S., Ticozzi, C., Romeo, D., Schieppati, F., Barcella, L., and Sarmiento, R. (2025). Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy. Cancers, 17.","DOI":"10.3390\/cancers17162712"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Helfer, H., Skaff, Y., Happe, F., Djennaoui, S., Chidiac, J., Po\u00e9nou, G., Righini, M., and Mah\u00e9, I. (2023). Diagnostic Approach for Venous Thromboembolism in Cancer Patients. Cancers, 15.","DOI":"10.3390\/cancers15113031"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7302\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:55Z","timestamp":1786974175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":55,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167302"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167302","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}